Heart drug tested to halt Parkinson's before symptoms start
NCT ID NCT04218968
Summary
This study is testing whether a medication called carvedilol, commonly used for heart conditions and high blood pressure, can slow down the brain changes that lead to Parkinson's disease. It involves 15 people who are at high risk for Parkinson's because they have a specific sleep disorder and other early warning signs. Researchers will use brain scans over three years to see if the drug helps preserve brain function and delays the onset of movement problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REM SLEEP BEHAVIOR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michele L Lima Gregorio
Los Angeles, California, 90046, United States
Conditions
Explore the condition pages connected to this study.